Aug 8 (Reuters) - Neurobo Pharmaceuticals Inc NRBO.O:

• NEUROBO PHARMACEUTICALS - GOT LETTER FROM NASDAQ ADVISING CO HAD BEEN GRANTED EXTENSION TO FEB 5, 2024 TO REGAIN COMPLIANCE WITH LISTING REQUIREMENT

Further company coverage: NRBO.O

(( reuters.briefs@thomsonreuters.com ;))

(c) Copyright Thomson Reuters 2023. Click For Restrictions - https://agency.reuters.com/en/copyright.html